Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1990 1
1993 2
1996 1
1998 1
1999 2
2000 3
2001 1
2002 4
2003 1
2004 3
2005 3
2006 2
2007 2
2008 2
2009 4
2010 7
2011 10
2012 6
2013 2
2014 6
2015 11
2016 8
2017 12
2018 13
2019 8
2020 20
2021 13
2022 16
2023 16
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Carotid Intima-Media Thickness for Atherosclerosis.
Nezu T, Hosomi N, Aoki S, Matsumoto M. Nezu T, et al. J Atheroscler Thromb. 2016;23(1):18-31. doi: 10.5551/jat.31989. Epub 2015 Oct 13. J Atheroscler Thromb. 2016. PMID: 26460381 Free article. Review.
Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailty.
Nagatomi Y, Ide T, Higuchi T, Nezu T, Fujino T, Tohyama T, Nagata T, Higo T, Hashimoto T, Matsushima S, Shinohara K, Yokoyama T, Eguchi A, Ogusu A, Ikeda M, Ishikawa Y, Yamashita F, Kinugawa S, Tsutsui H. Nagatomi Y, et al. Among authors: nezu t. ESC Heart Fail. 2022 Aug;9(4):2407-2418. doi: 10.1002/ehf2.13934. Epub 2022 May 9. ESC Heart Fail. 2022. PMID: 35534907 Free PMC article. Clinical Trial.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Novel partial deletions, frameshift and missense mutations of CSF1R in patents with CSF1R-related leukoencephalopathy.
Ishiguro T, Konno T, Hara N, Zhu B, Okada S, Shibata M, Saika R, Kitano T, Toko M, Nezu T, Hama Y, Kawazoe T, Takahashi-Iwata I, Yabe I, Sato K, Takeda H, Toda S, Nishimiya J, Teduka T, Nozaki H, Kasuga K, Miyashita A, Onodera O, Ikeuchi T. Ishiguro T, et al. Among authors: nezu t. Eur J Neurol. 2023 Jul;30(7):1861-1870. doi: 10.1111/ene.15796. Epub 2023 Mar 30. Eur J Neurol. 2023. PMID: 36943150
Regaining enamel color quality using enamel matrix derivative.
Sugaya H, Kurashige Y, Suzuki K, Sakakibara S, Fujita Y, Islam ST, Nezu T, Ito S, Abiko Y, Saitoh M. Sugaya H, et al. Among authors: nezu t. Med Mol Morphol. 2023 Jun;56(2):116-127. doi: 10.1007/s00795-022-00346-5. Epub 2023 Jan 9. Med Mol Morphol. 2023. PMID: 36622467 Free PMC article.
158 results